Senior Health Care Analyst Marshall Gordon joins Yahoo! Finance to discuss the implications of positive COVID-19 vaccine trials from Pfizer and Moderna and the likely timeline for vaccine approval and availability. He points out that the equity market has likely already priced in the upside from vaccine success and discusses the impact of having several competing vaccines.
